Seoul High Court dismisses appeal against Dongsung Pharmaceutical rehabilitation plan approval

Bitget2026/09/30 10:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Seoul High Court dismissed an immediate appeal challenging approval of Dongsung Pharmaceutical’s rehabilitation plan on Sept. 30, 2026.
The court upheld the first-instance decision, finding the appeal lacked merit.
The appellant was ordered to pay the appeal costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dongsung Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930801211), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Seoul High Court dismisses appeal against Dongsung Pharmaceutical rehabilitation plan approval

You may also like

Crypto prices